Clinical trials: Early Breast Cancer Detection
Breast Cancer
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
The goal of this study is to evaluate if adding community services navigation to the standard referral process for social needs is an effective and scalable strategy for addressing disparities in follow-up to abnormal breast…
- Trial name
- B-SINCERE (NCT06305312)
- Testing
- Community Service Navigation, Usual Care
- Where
- United States
- Volunteers
- 1,450 people
- Sponsor
- University of Utah
Breast Cancer
A Randomized Cluster Trial to Evaluate a Mobile Mammography Unit in Breast Cancer Screening in France (Mammobile)
Organized breast cancer screening (OBCS) has been implemented nationwide since 2004 inFrance, but the participation rate remains low (51%) and inequities in participation were reported.
- Trial name
- Mammobile (NCT05164874)
- Testing
- Mobile Mammography Unit
- Where
- France
- Volunteers
- 91,982 people, healthy volunteers welcome
- Sponsor
- Université de Caen Normandie
Breast Cancer, Myocardial Damage
Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping
Anthracyclines (e.g. Doxorubicin) are an important and highly effective chemotherapeutic. They are used in various tumor entities and are established for breast cancer treatment.
- Conditions
- Breast Cancer, Myocardial Damage, Cardiotoxicity
- Trial name
- ANKE (NCT03940625)
- Testing
- Cardiac MRI and echocardiography, laboratory parameters
- Where
- Germany
- Volunteers
- 69 people
- Sponsor
- Heinrich-Heine University, Duesseldorf
Breast Cancer
Prospective Chart-Review: Impact of Combination - Digital Breast Tomosynthesis + Digital Mammography
Digital Breast Tomosynthesis (DBT) is a technology that has been developed to improve lesion detection in dense breasted women. Even though DBT has been regarded as a study for dense breasted women, it may also improve lesion…
- Trial name
- NCT01593384
- Volunteers
- healthy volunteers welcome
- Sponsor
- Case Comprehensive Cancer Center
Breast Cancer
Digital Education for Breast Cancer Screening Beliefs and Prevention Behaviors
This randomized study compared three ways of delivering standardized digital education about breast cancer and early detection among adult women.
- Trial name
- NCT07820124
- Testing
- Instagram-Based Breast Cancer Education, Website-Based Breast Cancer Education, E-Brochure Breast Cancer Education
- Where
- Turkey (Türkiye)
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Gümüşhane Universıty
Breast Cancer Risk, Ovarian Cancer Risk
Population Based Germline Testing for Early Detection and Prevention of Cancer
PROTECT-C is a research study offering genetic testing to people to see whether they have a genetic change that increases their risk of breast, ovary, bowel, and/or womb cancer.
- Conditions
- Breast Cancer Risk, Ovarian Cancer Risk, Cancer Gene Mutation
- Trial name
- PROTECT-C (NCT07498829)
- Testing
- Genetic testing for Cancer Susceptibility Genes (CSGs) (BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2, MLH1, MSH2, MSH6) and personalised breast and ovarian cancer risk
- Where
- United Kingdom
- Volunteers
- 6,000 people, healthy volunteers welcome
- Sponsor
- Queen Mary University of London
Attendance, Breast Cancer Screening
The Effect on Attendance of an SMS Notification Prior to a Scheduled Screening Appointment in BreastScreen Norway
This study has been designed as a randomized controlled trial including women invited to a national screening program for breast cancer in Norway, BreastScreen Norway in 2025.
- Trial name
- NCT07355569
- Testing
- SMS notification
- Where
- Norway
- Volunteers
- 133,770 people, healthy volunteers welcome
- Sponsor
- Norwegian Institute of Public Health
Breast Cancer, Breast Cancer Risk
Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme
This prospective study evaluates whether a more detailed clinical and genetic assessment can improve the classification of individual breast cancer risk among women previously identified as having moderately increased or high…
- Trial name
- NCT07734389
- Testing
- Comprehensive Clinical and Genetic Breast Cancer Risk Assessment
- Where
- Slovenia
- Volunteers
- 291 people
- Sponsor
- Institute of Oncology Ljubljana
Breast Cancer
Trivandrum Breast Cancer Screening Trial
Cluster-randomized controlled trial in Trivandrum district, Kerala, India to evaluate the effect of triennial screening for breast cancer using clinical breast examination on breast cancer mortality.
- Trial name
- TBCS (NCT05301296)
- Testing
- Clinical examination of the breast for early detection of Cancer
- Volunteers
- 115,290 people, healthy volunteers welcome
- Sponsor
- International Agency for Research on Cancer